Funds
HELIUM ALPHA - B
Launched in September 2017, the Helium Alpha fund relies on a quantitative equity long/short hybrid strategy, also called Quantamental which combines quantitative and fundamental portfolio management approaches.
Invested in Europe, Helium Alpha is an absolute performance fund moderately correlated with the equity markets.
VALUE
MTD
AuM of the share class
5.0 k €
YTD
EVOLUTION OF THE FUND
KEY FIGURES (rolling year)
| 1 year | 3 years | 5 years | Launch | |
|---|---|---|---|---|
| Accumulated Performance | 1% | 4.7% | -2.6% | 0.2% |
| Annualized Performance | 1% | 1.6% | -0.5% | - |
| % positive months | 50% | 52.8% | 50% | 52.2% |
| Perf. Monthly Average | 0.1% | 0.2% | - | - |
| Annualized Volatility | 4.9% | 5.3% | 6.1% | 6.1% |
| Sharpe Ratio | - | 0.3 | -0.1 | - |
| Drawdown Max | -4.5% | -6.2% | -12.6% | -13.5% |
This is a marketing communication. Past performance is no guarantee of future performance. The investment presents a risk of capital loss. Before any investment, please refer to the risks and various costs of each share class available in the prospectus and the KIIDs.
PERFORMANCE SINCE INCEPTION IN %
| January | February | March | April | May | June | July | August | September | October | November | December | Ytd Perf% | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -1.87% | -1.59% | 0.71% | -0.20% | -0.42% | -3.35% | |||||||
| 2022 | -1.58% | 0.31% | 2.34% | -0.89% | -1.26% | 2.19% | 1.19% | 0.83% | 0.01% | 0.82% | -0.46% | -0.07% | 3.38% |
| 2021 | 1.20% | 0.77% | 3.15% | 1.62% | 2.30% | -0.95% | 1.61% | -1.46% | 1.83% | 0.01% | -0.73% | 1.78% | 11.60% |
| 2020 | 1.26% | -1.04% | -1.22% | 0.87% | 0.23% | -0.71% | 0.56% | -1.35% | 0.04% | -1.54% | -1.87% | -1.35% | -6.00% |
| 2019 | 2.30% | 1.36% | 0.36% | -1.69% | 0.11% | -0.14% | 0.00% | -0.69% | -0.63% | -0.55% | 1.29% | -1.17% | 0.47% |
| 2018 | 0.74% | -1.59% | -0.40% | 1.11% | 0.13% | -1.91% | 0.22% | 0.14% | 0.02% | -2.22% | -3.15% | -0.56% | -7.37% |
| 2017 | 0.54% | 0.85% | -0.36% | 1.62% | 2.66% |
This is a marketing communication. Past performance is no guarantee of future performance. The investment presents a risk of capital loss. Before any investment, please refer to the risks and various costs of each share class available in the prospectus and the KIIDs.
INFORMATION ELEMENTS
| Inception | 22/09/2017 |
|---|---|
| FCP Structure | SICAV - UCITS |
| Volatility objective | 5% - 7% |
| Recommended investment period | 5 years |
| Liquidity / NAV | Weekly |
| Deadline | Thursday before 5 pm CET |
| Senior Manager | Olivier Leymarie |
| Code ISIN | LU1685859180 |
| Code Bloomberg | HEALBEC LX |
| SFDR | Article 8 |
| Base currency | EUR |
|---|---|
| Domicile | Luxembourg |
| Administrator | CACEIS Bank Luxembourg |
| Auditor | Deloitte & Touche |
| Minimum initial subscription | EUR 5 000 |
| Management fees | 2.00% |
| Performance fees | 20% High Water Mark |
| Hurdle | SOFR |
| Assignment result | Capitalization |